ACM
BSX icon

Anfield Capital Management’s Boston Scientific BSX Stock Holding History

Anfield Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
167
+151
+944% +$12.1K ﹤0.01% 428
2025
Q4 		$1.53K Sell
16
-23,509
-100% -$2.3M ﹤0.01% 480
2025
Q3 		$2.3M Buy
+23,525
New +$2.44M 0.68% 40

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Anfield Capital Management's BSX Position: Q1 2026 in Review

Anfield Capital Management increased its Boston Scientific (BSX) stake by 944% in Q1 2026, buying an estimated $12.1K and bringing the position to 167 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Anfield Capital Management first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.3M in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Anfield Capital Management held 167 shares of Boston Scientific worth $10.5K as of Q1 2026.
  • Anfield Capital Management bought 151 Boston Scientific shares in Q1 2026, an estimated $12.1K.
  • Boston Scientific made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #428 holding.
  • Anfield Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • Anfield Capital Management's Boston Scientific position peaked at $2.3M in Q3 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.